Avalo Therapeutics, Inc.

The current price of AVTX is 13.78 USD — it has increased by 5.96% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Avalo Therapeutics, Inc. stocks are traded under the ticker AVTX.

Avalo Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

AVTX stock is 9.06% volatile and has beta coefficient of 0.44. Check out the list of the most volatile stocks — is Avalo Therapeutics, Inc. there?

AVTX earnings for the last quarter are −26.40 USD per share, whereas the estimation was −264.00 USD resulting in a 90.00% surprise. The estimated earnings for the next quarter are −4.80 USD per share. See more details about Avalo Therapeutics, Inc. earnings.

Avalo Therapeutics, Inc. revenue for the last quarter amounts to ‪236.00 K‬ USD despite the estimated figure of ‪1.00 M‬ USD. In the next quarter revenue is expected to reach ‪300.00 K‬ USD.

Yes, you can track Avalo Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

AVTX stock has fallen by 11.81% compared to the previous week, the month change is a 196.24% rise, over the last year Avalo Therapeutics, Inc. has showed a 98.17% decrease.

Today Avalo Therapeutics, Inc. has the market capitalization of ‪13.44 M‬, it has decreased by 23.40% over the last week.

No, AVTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, AVTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avalo Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

AVTX reached its all-time high on Feb 27, 2019 with the price of 22031.71 USD, and its all-time low was 3.95 USD and was reached on Jan 17, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 24, 2024, the company has 19.00 employees. See our rating of the largest employees — is Avalo Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Avalo Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Avalo Therapeutics, Inc. stock shows the sell signal. See more of Avalo Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Avalo Therapeutics, Inc. future price: according to them, AVTX price has a max estimate of 35.00 USD and a min estimate of 35.00 USD. Read a more detailed Avalo Therapeutics, Inc. forecast: see what analysts think of Avalo Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Avalo Therapeutics, Inc. EBITDA is ‪−23.55 M‬ USD, and current EBITDA margin is ‪−1.21 K‬%. See more stats in Avalo Therapeutics, Inc. financial statements.